Ariel Levy, APRN, PPNP-BC, CPHON

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Topic:
    Educating community members on topics relating to hemophilia. Content is unbranded and does not name or endorse any products.
    Date added:
    03/12/2025
    Date updated:
    03/12/2025
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Genentech
    Topic:
    Providing feedback related to the hemophilia treatment space and how their product, emicizumab, fits into it. This happens over a one day meeting.
    Date added:
    03/12/2025
    Date updated:
    03/12/2025
    Relationship end date:
    03/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Octapharma
    Topic:
    Providing feedback related to the hemophilia treatment space and how their product, emicizumab, fits into it. This happens over a one day meeting.
    Date added:
    03/12/2025
    Date updated:
    03/12/2025
    Relationship end date:
    03/12/2025
Return to Hemophilia and Factor